Glipq-4mg Vial

GLIPIQ 4mg Injection contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is supplied as a multiple-dose injection containing Semaglutide 4 mg/3 mL (1.34 mg/mL). The product is intended for once-weekly subcutaneous use. GLIPIQ 4mg Injection is used as part of a weight management plan along with a reduced-calorie diet and increased physical activity. It is a prescription medicine and should be used under medical supervision.

GLIPIQ 4mg Injection may be prescribed for: Long-term weight management: Semaglutide may be used in adults with obesity. Overweight with weight-related health problems: It may be prescribed for adults who are overweight and have a weight-related health condition. GLIPIQ should be used along with a suitable diet and regular physical activity. The dose is selected and adjusted by the doctor based on the individual's response and treatment plan. Do not change the dose without medical advice.

GLIPIQ 4mg Injection is given as a subcutaneous injection once weekly, exactly as prescribed by your doctor. It can be injected into areas such as the abdomen, thigh, or upper arm. Rotate the injection site when possible. Your doctor or healthcare professional should show you how to prepare and administer the injection before your first dose. GLIPIQ can be administered with or without food. Use the prescribed dose only. Do not change the dose or weekly schedule without consulting your doctor.

Common side effects of GLIPIQ 4mg Injection may include: Nausea Vomiting Diarrhoea Constipation Abdominal pain Decreased appetite Indigestion Headache Fatigue These effects are more common when treatment is started or the dose is increased and may improve as the body adjusts. Seek medical attention if you develop severe or persistent abdominal pain, especially if it spreads to the back, as this may be a sign of pancreatitis. Contact your doctor if you develop symptoms of gallbladder problems, dehydration, or a serious allergic reaction.

Pregnancy Unsafe Semaglutide should not be used during pregnancy. If you become pregnant while using GLIPIQ, contact your doctor promptly. Women planning a pregnancy should discuss treatment with their doctor beforehand. Semaglutide should generally be stopped at least 2 months before a planned pregnancy. Breast Feeding Consult Your Doctor Tell your doctor if you are breastfeeding before using GLIPIQ 4mg Injection. Your doctor will decide whether treatment is appropriate based on your individual circumstances. Lungs Consult Your Doctor Semaglutide does not have specific routine lung-related precautions. Tell your doctor about any significant respiratory condition and inform your healthcare team if you are scheduled for surgery or a procedure requiring general anaesthesia or deep sedation. Liver Consult Your Doctor Tell your doctor if you have liver disease before starting GLIPIQ 4mg Injection. Your doctor will decide whether any additional monitoring or treatment adjustments are needed. Alcohol Consult Your Doctor Alcohol may worsen gastrointestinal symptoms such as nausea and vomiting and can contribute to dehydration. If you have diabetes or use medicines that can cause low blood

2 - 8°C